Showing results (1731-1740 of 1,772) with videos related to
Sort By:
Pageof 178
EJNMMI Physics|November 22, 2023
On the use of solid <sup>133</sup>Ba sources as surrogate for liquid <sup>131</sup>I in SPECT/CT calibration: a European multi-centre evaluationJohannes Tran-Gia, Ana M Denis-Bacelar, Kelley M Ferreira, et al.Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.Journal of Medicinal Chemistry|December 14, 2012
Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119Etzer Darout, Ralph P Robinson, Kim F McClure, et al.Blood Cancer Journal|April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genesNicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.Journal of Medicinal Chemistry|April 1, 2011
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitorsVincent Mascitti, Tristan S Maurer, Ralph P Robinson, et al.Nature|September 8, 2006
Structure of the insulin receptor ectodomain reveals a folded-over conformationNeil M McKern, Michael C Lawrence, Victor A Streltsov, et al.Blood Advances|June 23, 2020
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significanceAlyssa I Clay-Gilmour, Michelle A T Hildebrandt, Elizabeth E Brown, et al.Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.Pageof 178